(Q51173442)

31 March 2018

title

Technical risks with subcutaneous insulin infusion. (English)

1 reference

31 March 2018

1 reference

Guilhem I

1

1 reference

31 March 2018

Leguerrier AM

2

1 reference

31 March 2018

Lecordier F

3

1 reference

31 March 2018

Poirier JY

4

1 reference

31 March 2018

Maugendre D

5

1 reference

31 March 2018

publication date

1 June 2006

1 reference

31 March 2018

published in

Diabetes and Metabolism

1 reference

31 March 2018

volume

32

1 reference

31 March 2018

issue

3

1 reference

31 March 2018

page(s)

279-284

1 reference

31 March 2018

Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970281-1

7 January 2021

Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970281-1

7 January 2021

Insulin pump therapy: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970281-1

7 January 2021

Diabetic ketoacidosis during long-term treatment with continuous subcutaneous insulin infusion

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970281-1

7 January 2021

Malfunction of continuous subcutaneous insulin infusion systems: a one-year prospective study of 127 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970281-1

7 January 2021

Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for type 1 (insulin-dependent) diabetes mellitus: a one centre experience

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970281-1

7 January 2021

Catheter obstruction with continuous subcutaneous insulin infusion. Effect of insulin concentration

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970281-1

7 January 2021

Conference on insulin pump therapy in diabetes. Multicenter study of effect on microvascular disease. The pump life. Patient responses and clinical and technological problems

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970281-1

7 January 2021

Acute complications associated with insulin infusion pump therapy. Report of experience with 161 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970281-1

7 January 2021

Mortality among diabetic patients using continuous subcutaneous insulin-infusion pumps

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970281-1

7 January 2021

Cutaneous complication of CSII therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970281-1

7 January 2021

Acute cutaneous complications and catheter needle colonization during insulin-pump treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970281-1

7 January 2021

Complications of insulin pump therapy: the effect of insulin preparation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970281-1

7 January 2021

Stability of insulin lispro in insulin infusion systems.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970281-1

7 January 2021

Metabolic decompensation in pump users due to lispro insulin precipitation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970281-1

7 January 2021

Comparison of insulin aspart with buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970281-1

7 January 2021

Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusion

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970281-1

7 January 2021

10.1016/S1262-3636(07)70281-1

Identifiers

DOI

1 reference

31 March 2018

PubMed ID

16799407

1 reference

31 March 2018